Literature DB >> 10923246

Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase.

H Kim1, G L Yung, J J Marsh, R G Konopka, C A Pedersen, P G Chiles, T A Morris, R N Channick.   

Abstract

There is increasing evidence that the pathogenesis and progression of many forms of pulmonary vasculopathy are related to abnormalities in endothelial mediators, including endothelin-1 (ET-1) and nitric oxide (NO). Using a rat model of chronic unilateral pulmonary artery ligation, we investigated the role of ET-1 and NO in postobstructive pulmonary vasculopathy (POPV). Eight months after a left thoracotomy with either left main pulmonary artery ligation (ligated group) or no ligation (sham group), rat lungs, including those contralateral to the ligation (hyperperfused group), were fixed and mounted for histologic sectioning. Morphometric measurements were carried out by computer-assisted image analysis and immunohistochemical staining was performed using specific antibodies against ET-1, ETA, and EBB receptors, and endothelial NO synthase (eNOS). Compared to sham lungs, the ligated lungs showed (1) an increase in muscular, adventitial, and intimal thickness of pulmonary artery; (2) increase in external diameter of the bronchial artery (39.8 +/- 2.2 microns vs. 16.8 +/- 0.9 microns in sham group; P < .005) and number of bronchial arteries per bronchiole (3.21 +/- mu 0.26 vs. 1.86 +/- mu 0.21 in sham group; P < .001); and (3) increase in the intensity of eNOS and ETA, B receptor immunoreactivity. No morphometric or immunohistochemical differences were observed between the hyperperfused and sham lungs. These findings suggest that increased synthesis of endothelial NO may serve as a compensatory mediator in ET-1-mediated vascular remodeling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10923246     DOI: 10.1080/019021400404555

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  6 in total

Review 1.  Structure and composition of pulmonary arteries, capillaries, and veins.

Authors:  Mary I Townsley
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

Review 2.  Chronic thromboembolic pulmonary hypertension.

Authors:  H J Reesink; J J Kloek; P Bresser
Journal:  Neth Heart J       Date:  2006-06       Impact factor: 2.380

Review 3.  Endothelin receptor antagonists for pulmonary arterial hypertension.

Authors:  Chao Liu; Junmin Chen; Yanqiu Gao; Bao Deng; Kunshen Liu
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

4.  Bronchial circulation angiogenesis in the rat quantified with SPECT and micro-CT.

Authors:  Christian Wietholt; David L Roerig; John B Gordon; Steven T Haworth; Robert C Molthen; Anne V Clough
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-02-05       Impact factor: 9.236

5.  Connection of discontinuous pulmonary arteries in patients with a superior or total cavopulmonary circulation.

Authors:  Emile A Bacha; Peter Lang; John E Mayer; Doff B McElhinney
Journal:  Ann Thorac Surg       Date:  2008-12       Impact factor: 4.330

6.  Results of Macitentan in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension - A Prospective, Multicenter, Open-Label, Single-Arm, Phase 3 Study.

Authors:  Satomi Sakurai; Yoshifumi Ukyo
Journal:  Circ Rep       Date:  2021-06-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.